Macquarie Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.35M Sell
181,917
-104,965
-37% -$1.94M ﹤0.01% 1073
2025
Q1
$5.01M Sell
286,882
-4,205
-1% -$73.5K 0.01% 979
2024
Q4
$5.04M Buy
291,087
+21,907
+8% +$379K 0.01% 948
2024
Q3
$5.01M Buy
269,180
+4,735
+2% +$88.1K 0.01% 964
2024
Q2
$4.07M Buy
264,445
+3,527
+1% +$54.3K ﹤0.01% 1024
2024
Q1
$3.84M Buy
260,918
+2,892
+1% +$42.5K ﹤0.01% 1036
2023
Q4
$3.68M Buy
258,026
+35,651
+16% +$509K ﹤0.01% 1042
2023
Q3
$3.1M Buy
222,375
+81,990
+58% +$1.14M ﹤0.01% 1045
2023
Q2
$1.65M Buy
140,385
+3,216
+2% +$37.8K ﹤0.01% 1238
2023
Q1
$1.58M Sell
137,169
-6,902
-5% -$79.4K ﹤0.01% 1235
2022
Q4
$1.79M Sell
144,071
-49,815
-26% -$619K ﹤0.01% 1242
2022
Q3
$2.63M Sell
193,886
-26,956
-12% -$365K ﹤0.01% 1144
2022
Q2
$3.13M Sell
220,842
-4,299
-2% -$60.9K ﹤0.01% 1149
2022
Q1
$3.35K Sell
225,141
-28,910
-11% -$430 ﹤0.01% 1226
2021
Q4
$3.44M Buy
254,051
+17,785
+8% +$241K ﹤0.01% 1222
2021
Q3
$3.48M Sell
236,266
-13,393
-5% -$197K ﹤0.01% 1204
2021
Q2
$4.54M Buy
249,659
+16,904
+7% +$308K ﹤0.01% 1156
2021
Q1
$4.04M Buy
232,755
+48,784
+27% +$847K 0.01% 968
2020
Q4
$3.2M Sell
183,971
-175,103
-49% -$3.04M ﹤0.01% 977
2020
Q3
$4.95M Sell
359,074
-79,706
-18% -$1.1M 0.01% 837
2020
Q2
$6.33M Buy
438,780
+281,007
+178% +$4.05M 0.01% 746
2020
Q1
$1.72M Buy
157,773
+5,561
+4% +$60.7K ﹤0.01% 953
2019
Q4
$3.25M Buy
152,212
+37,337
+33% +$797K ﹤0.01% 907
2019
Q3
$2.64M Sell
114,875
-4,601
-4% -$106K ﹤0.01% 952
2019
Q2
$2.35M Buy
119,476
+7,825
+7% +$154K ﹤0.01% 977
2019
Q1
$2.17M Sell
111,651
-354,380
-76% -$6.9M ﹤0.01% 973
2018
Q4
$7.68M Sell
466,031
-192,899
-29% -$3.18M 0.01% 649
2018
Q3
$15.2M Buy
658,930
+226,604
+52% +$5.24M 0.02% 545
2018
Q2
$9.4M Buy
432,326
+269,426
+165% +$5.85M 0.02% 653
2018
Q1
$2.88M Buy
162,900
+105,880
+186% +$1.87M 0.01% 887
2017
Q4
$124K Sell
57,020
-229,097
-80% -$498K ﹤0.01% 1859
2017
Q3
$6.28M Buy
286,117
+254,039
+792% +$5.57M 0.01% 704
2017
Q2
$773K Buy
32,078
+5,775
+22% +$139K ﹤0.01% 1226
2017
Q1
$734K Buy
26,303
+7,800
+42% +$218K ﹤0.01% 1250
2016
Q4
$452K Sell
18,503
-5,700
-24% -$139K ﹤0.01% 1340
2016
Q3
$609K Sell
24,203
-12,003
-33% -$302K ﹤0.01% 1258
2016
Q2
$746K Buy
36,206
+20,528
+131% +$423K ﹤0.01% 1326
2016
Q1
$315K Sell
15,678
-6,800
-30% -$137K ﹤0.01% 1302
2015
Q4
$455K Buy
22,478
+6,650
+42% +$135K ﹤0.01% 1195
2015
Q3
$367K Buy
15,828
+1,525
+11% +$35.4K ﹤0.01% 1304
2015
Q2
$368K Buy
14,303
+7,500
+110% +$193K ﹤0.01% 1353
2015
Q1
$225K Sell
6,803
-10,875
-62% -$360K ﹤0.01% 1394
2014
Q4
$537K Sell
17,678
-107,891
-86% -$3.28M ﹤0.01% 1250
2014
Q3
$3.05M Sell
125,569
-374,794
-75% -$9.12M 0.01% 857
2014
Q2
$14.4M Buy
500,363
+242,094
+94% +$6.95M 0.03% 434
2014
Q1
$7.2M Buy
258,269
+24,930
+11% +$695K 0.01% 577
2013
Q4
$6.1M Buy
233,339
+218,339
+1,456% +$5.71M 0.01% 583
2013
Q3
$345K Sell
15,000
-13,000
-46% -$299K ﹤0.01% 1322
2013
Q2
$731K Buy
+28,000
New +$731K ﹤0.01% 1209